Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Sanofi (SNY) EBT Margin (2016 - 2025)

Historic EBT Margin for Sanofi (SNY) over the last 17 years, with Q4 2025 value amounting to 49.31%.

  • Sanofi's EBT Margin rose 237300.0% to 49.31% in Q4 2025 from the same period last year, while for Dec 2025 it was 14.66%, marking a year-over-year decrease of 91600.0%. This contributed to the annual value of 16.74% for FY2025, which is 47900.0% down from last year.
  • As of Q4 2025, Sanofi's EBT Margin stood at 49.31%, which was up 237300.0% from 24.66% recorded in Q3 2025.
  • Sanofi's 5-year EBT Margin high stood at 103.46% for Q4 2022, and its period low was 0.15% during Q4 2021.
  • For the 5-year period, Sanofi's EBT Margin averaged around 26.92%, with its median value being 24.87% (2025).
  • Per our database at Business Quant, Sanofi's EBT Margin surged by 1036100bps in 2022 and then tumbled by -821700bps in 2023.
  • Quarter analysis of 5 years shows Sanofi's EBT Margin stood at 0.15% in 2021, then skyrocketed by 70920bps to 103.46% in 2022, then plummeted by -79bps to 21.29% in 2023, then increased by 20bps to 25.58% in 2024, then soared by 93bps to 49.31% in 2025.
  • Its last three reported values are 49.31% in Q4 2025, 24.66% for Q3 2025, and 8.28% during Q2 2025.